PODD · Insulet Corporation

S&P 500 #472 · Nasdaq

Risiko 7/10 · High Growth, High Volatility · $167.47 ▲ 1.50%

Kennzahlen

• Price $167.47
• Market cap $11.6B
• P/E (ttm) 39.22
• Div yield none
• 52-wk range $138.79 – $354.88
• Index rank #472 / —

Wichtigste Risiken

• Stock down ~55% from 52-week high (Shareholders) — EXTREME
• Competition from Abbott/Medtronic CGM-pump combos (Market share) — HIGH
• Product recall / regulatory risk (OmniPod) (Revenue & brand) — HIGH
• Valuation premium despite slowdown (Multiple compression) — HIGH

Fazit

Maker of tubeless OmniPod insulin delivery system; deep drawdown from highs despite strong diabetes device market tailwinds.

Interaktive Analyse öffnen → Teilen

Recherche, keine Anlageberatung.